Literature DB >> 23751754

From NAFLD in clinical practice to answers from guidelines.

Fabio Nascimbeni1, Raluca Pais, Stefano Bellentani, Christopher Paul Day, Vlad Ratziu, Paola Loria, Amedeo Lonardo.   

Abstract

This review of the literature consists of three sections. First, papers concerning non-alcoholic fatty liver disease (NAFLD) awareness among the general population, general practitioners, and liver and non-liver specialists were retrieved and analyzed to highlight the perception of disease, verify knowledge of current recommendations, and identify the main difficulties experienced in clinical practice. Next, position papers and clinical practice guidelines issued by International and National Hepatological Scientific Societies were identified and critically assessed in order to pinpoint the areas of convergence/difference. Finally, practical suggestions on NAFLD diagnosis and management in daily practice are provided and the open questions highlighted.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AASLD; ACG; AFLD; AGA; APWP; American Association for the Study of Liver Disease; American College of Gastroenterology; American Gastroenterological Association; Asian-Pacific Working Party; CLD; CLDA; CVD; Chinese Liver Disease Association; Clinical practice; EASL; ESPGHAN; European Association for the Study of the Liver; European Society for Pediatric Gastroenterology, Hepatology and Nutrition; GPs; Guidelines; HCC; IASL; IR; Italian Association for the Study of the Liver; LB; LTs; MRFs; MS; NAFLD; NASH; T2D; US; alcoholic fatty liver disease; cardiovascular disease; chronic liver disease; general practitioners; hepatocellular carcinoma; insulin resistance; liver biopsy; liver tests; metabolic risk factors; metabolic syndrome; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; type 2 diabetes; ultrasonography

Mesh:

Year:  2013        PMID: 23751754     DOI: 10.1016/j.jhep.2013.05.044

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  120 in total

Review 1.  Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Authors:  Tannaz Eslamparast; Sareh Eghtesad; Hossein Poustchi; Azita Hekmatdoost
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Prevalence of fatty liver disease and the economy in China: A systematic review.

Authors:  Jin-Zhou Zhu; Qin-Yi Zhou; Yu-Ming Wang; Yi-Ning Dai; Jiang Zhu; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

3.  Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.

Authors:  Christopher Leung; Sern Wei Yeoh; Desmond Patrick; Shara Ket; Kaye Marion; Paul Gow; Peter W Angus
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 4.  Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.

Authors:  Hiroyasu Sakai; Yohei Shirakami; Masahito Shimizu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Cost-utility analysis of nonalcoholic steatohepatitis screening.

Authors:  Eric Zhang; Claire Wartelle-Bladou; Luigi Lepanto; Jean Lachaine; Guy Cloutier; An Tang
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

Review 6.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit.

Authors:  Pao-Yuan Lin; Chih-Hung Chen; Christopher Glenn Wallace; Kuan-Hung Chen; Chia-Lo Chang; Hong-Hwa Chen; Pei-Hsun Sung; Kun-Chen Lin; Sheung-Fat Ko; Cheuk-Kwan Sun; Hsueh-Wen Chang; Pei-Lin Shao; Mel S Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

8.  CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

Authors:  Ratanesh Kumar Seth; Suvarthi Das; Ashutosh Kumar; Anindya Chanda; Maria B Kadiiska; Gregory Michelotti; Jose Manautou; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

Review 9.  Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

Authors:  Ludovico Abenavoli; Natasa Milic; Valentina Peta; Francesco Alfieri; Antonino De Lorenzo; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 10.  Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Authors:  Ivana Mikolasevic; Lidija Orlic; Neven Franjic; Goran Hauser; Davor Stimac; Sandra Milic
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.